HR 5708 · 118th Congress · Health
MCM PRV Reauthorization Act
Bill Progress
✓
Introduced2
Committee3
House Vote4
Senate5
EnactedLatest: Referred to the Subcommittee on Health.(2023-09-29)
Plain Language Summary
[AI summary unavailable — showing source text]
[Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 5708 Introduced in House (IH)] <DOC> 118th CONGRESS 1st Session H. R. 5708 To amend the Federal Food, Drug, and Cosmetic Act to extend a priority review program to encourage treatments for agents that present national security threats. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES September 26, 2023 Mr. Finstad (for himself and Mr. Phillips) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to extend a priority review program to encourage treatments for agents that present national security threats. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``MCM PRV Reauthorization Act''. SEC. 2. EXTENSION OF PRIORITY REVIEW TO ENCOURAGE TREATMENTS FOR AGENTS THAT PRESENT NATIONAL SECURITY THREATS. Section 565A(g) of the Federal Food, Drug, and Cosmetic Act (21 …
Summarized by Claude AI · Non-partisan · For informational purposes only